148 related articles for article (PubMed ID: 33086961)
1. Bucillamine-induced gigantomastia with galactorrhea and hyperprolactinaemia.
Mori T; Yokogawa N; Higuchi R; Tsujino M; Shimada K; Sugii S
Mod Rheumatol Case Rep; 2020 Jan; 4(1):122-125. PubMed ID: 33086961
[TBL] [Abstract][Full Text] [Related]
2. Gigantomastia induced by bucillamine.
Sakai Y; Wakamatsu S; Ono K; Kumagai N
Ann Plast Surg; 2002 Aug; 49(2):193-5. PubMed ID: 12187348
[TBL] [Abstract][Full Text] [Related]
3. An exceptional case of bilateral gestational gigantomastia with multiple breast lumps.
Traoré B; Kamate B; Conde M; Keita AM; Kourouma T; Dem A
Pan Afr Med J; 2015; 20():309. PubMed ID: 26161232
[TBL] [Abstract][Full Text] [Related]
4. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
[TBL] [Abstract][Full Text] [Related]
5. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
[TBL] [Abstract][Full Text] [Related]
6. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis.
Kim HA; Song YW
Rheumatol Int; 1997; 17(1):5-9. PubMed ID: 9194208
[TBL] [Abstract][Full Text] [Related]
7. Bucillamine-induced yellow nail in Japanese patients with rheumatoid arthritis: two case reports and a review of 36 reported cases.
Nakagomi D; Ikeda K; Hirotoshi K; Kobayashi Y; Suto A; Nakajima H
Rheumatol Int; 2013 Mar; 33(3):793-7. PubMed ID: 22090009
[TBL] [Abstract][Full Text] [Related]
8. [A case of bucillamine-induced interstitial pneumonia].
Hara A; Sakamoto O; Matsumoto M; Sakata T; Kohrogi H; Sugimoto M; Ando M; Araki S; Iwakiri T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1743-8. PubMed ID: 1447852
[TBL] [Abstract][Full Text] [Related]
9. [A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine].
Matsushima H; Takayanagi N; Sakamoto T; Motegi M; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M; Kawabata Y
Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):55-9. PubMed ID: 11296388
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy-associated gigantomastia recurrence and ectopic breast after reduction mammaplasty: A case report.
Zhou M; Jin M; Wang L; Pan LJ
Cancer Biomark; 2017 Aug; 20(2):225-229. PubMed ID: 28869443
[TBL] [Abstract][Full Text] [Related]
11. A case of bucillamine-induced interstitial pneumonia with positive lymphocyte stimulation test for bucillamine using bronchoalveolar lavage lymphocytes.
Saito Y; Nei T; Abe S; Usuki J; Azuma A; Nakayama T; Fukuda Y; Kudoh S
Intern Med; 2007; 46(20):1739-43. PubMed ID: 17938531
[TBL] [Abstract][Full Text] [Related]
12. [A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment].
Negishi M; Yamazaki J; Hosaka M; Iwabuchi H; Matsuda A; Kanemitsu H; Hiramatsu K; Kaga S; Hashimoto M; Kasama T
Ryumachi; 1994 Jun; 34(3):651-5. PubMed ID: 8052932
[TBL] [Abstract][Full Text] [Related]
13. [A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis].
Kishimoto N; Fujii K
Nihon Kokyuki Gakkai Zasshi; 2002 Apr; 40(4):321-5. PubMed ID: 12096503
[TBL] [Abstract][Full Text] [Related]
14. [A case of progressive systemic sclerosis with Sjögren's syndrome complicated by nephrotic syndrome caused by bucillamine].
Ogawa N; Itoh M; Sudo Y; Endo S; Ohashi H; Okugawa T; Furuya R; Hishida A
Ryumachi; 1990 Oct; 30(5):362-6, 308; discussion 366-8. PubMed ID: 2084858
[TBL] [Abstract][Full Text] [Related]
15. [Lung injury associated with bucillamine therapy].
Negishi M; Kaga S; Kasama T; Hashimoto M; Fukushima T; Yamagata N; Tabata M; Kobayashi K; Ide H; Takahashi T
Ryumachi; 1992 Apr; 32(2):135-9. PubMed ID: 1595005
[TBL] [Abstract][Full Text] [Related]
16. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells.
Mita S; Matsunaga K
Agents Actions; 1990 Jun; 30(3-4):363-8. PubMed ID: 2386109
[TBL] [Abstract][Full Text] [Related]
17. [A case of rheumatoid arthritis with bucillamine-induced myasthenia gravis treated by immunoadsorption therapy].
Sawa N; Ubara Y; Hara S; Hideyuki K; Tagami T; Yokoyama K; Takemoto F; Yamada A; Mori T; Mikami A; Tachibana S; Nakase K
Ryumachi; 1999 Feb; 39(1):33-8. PubMed ID: 10332215
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological evaluation and treatment of bucillamine induced membranous nephropathy].
Kikuchi M; Saeki T; Ito S; In H; Saito T; Ueno M; Sato T; Suzuki S; Nakano M; Ozawa T
Ryumachi; 1993 Jun; 33(3):215-22. PubMed ID: 8346463
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effect of bucillamine (SA96) on interleukin-1-and/or -2-induced proliferation of T lymphocytes.
Sasano M; Goto M; Nishioka K
Agents Actions; 1990 Nov; 31(3-4):285-9. PubMed ID: 2085145
[TBL] [Abstract][Full Text] [Related]
20. Cortisone-induced gigantomastia during chemotherapy.
Troccola A; Maruccia M; Dessy LA; Onesti MG
G Chir; 2011 May; 32(5):266-9. PubMed ID: 21619780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
